A subcutaneously injected drug to promote long-term weight management.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Viekira Pak (Ombitasvir, Paritaprevir and Ritonavir Tablets Co-packaged With Dasabuvir tablets) All-Oral Regimen for HCV Genotype 1 Infection
An all-oral regimen for the treatment of hepatitis C virus genotype 1.
HeartFlow FFRCT
A software program that analyzes coronary computed tomography angiography images to provide an estimated measure of fractional flow reserve in coronary lesions of intermediate stenosis severity.
Symplicity Renal Denervation System
A percutaneous renal nerve ablation system used to interrupt renal sympathetic nerve activity and lower blood pressure in patients with treatment-resistant hypertension.
Stimwave Freedom Spinal Cord Stimulation System
A miniature wireless spinal cord stimulator.
inFlow Urinary Prosthesis
A temporary, indwelling intraurethral valve-pump proposed as an alternative to catheterization in women with impaired detrusor contractility.
Sonalleve MR-HIFU System
A system that combines magnetic resonance imaging guidance with high-intensity focused ultrasound for the noninvasive treatment of symptomatic uterine fibroids.
Actoxumab Plus Bezlotoxumab (MK-3415A; Formerly CDA1 and CDB1 Monoclonal Antibodies)
An intravenous solution combining fully humanized monoclonal antibodies against Clostridium difficile (C. difficile) toxins A and B proposed to reduce risk for C. difficile infection recurrence.
Single-Port Orifice Robotic Technology (SPORT) Surgical System
A next-generation robotic surgery system with haptic (tactile) feedback and operation via an Internet protocol, designed for single-port access surgical procedures performed via surgeon control in an operating room.
Lemtrada (Alemtuzumab) for Multiple Sclerosis
An intravenous anti-CD52 monoclonal antibody for treatment of relapsing forms of multiple sclerosis.